Syllabus
Pharmacovigilance Signal Detection and Risk Management Professional Certificate
36 lessons, about 14 hours. Online and self-paced.
Surveillance Foundations
Establish accountable roles, current regulatory expectations and a controlled surveillance plan.
- 1Signal Lifecycle and Accountable Roles
- 2Current EU Signal Obligations
- 3Product Surveillance Plan
- 4Competence and Outsourcing Controls
Data and Statistical Screening
Build reproducible safety datasets, calculate disproportionality measures and document defensible screening decisions.
- 5Safety Sources and Search Specifications
- 6Case Deduplication and Source Classification
- 7Counting Units and Contingency Tables
- 8PRR and ROR Calculations
- 9Bayesian Screening and Reporting Bias
- 10Public Dashboard Screening Decisions
- 11Verified Screening Worksheet
Signal Assessment and Escalation
Validate and prioritise signals, integrate clinical and epidemiological evidence and propose targeted evidence generation.
- 12Clinical Signal Validation Dossier
- 13Pregnancy and Breastfeeding Signal Assessment
- 14Signal Priority and Review Ownership
- 15EU and U.S. Escalation Pathways
- 16Integrated Signal Evidence Assessment
- 17Observed-to-Expected Analysis Appraisal
- 18Evidence Generation and PASS Proposal
Aggregate Safety Reporting
Plan jurisdiction-specific reporting and draft traceable PBRER and DSUR contributions with controlled quality review.
- 19Report Types and Reporting Clocks
- 20U.S. Periodic Reporting Requirements
- 21PBRER Signal and Benefit-Risk Contributions
- 22DSUR Development Safety Contribution
- 23ICSR and Aggregate Submission Interfaces
- 24Paired Aggregate Report Quality Review
Risk Management and Minimisation
Create distinct EU RMP and U.S. REMS deliverables with evidence-linked interventions and effectiveness measures.
- 25EU RMP Safety Specification
- 26Routine and Additional Risk Minimisation
- 27Risk-Minimisation Effectiveness Evaluation
- 28Embryo-Fetal Risk Minimisation Planning
- 29REMS Goals and Required Elements
- 30REMS Assessments and Lifecycle Changes
- 31EU RMP and REMS Drafts
Benefit-Risk Decisions and Verification
Integrate the portfolio into an evidence-supported committee recommendation and demonstrate competence through applied assessment.
- 32Benefit-Risk Evidence Framework
- 33Benefit-Risk Options and Recommendation
- 34Safety Committee Presentation and Challenge
- 35Decision Records and Regulatory Actions
- 36Portfolio Verification and Final Assessment




























